Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#What Is the Outlook for the Fluorescent In Situ Hybridization Probe Market Heading Into 2029?#_x000D_
The market size for fluorescent in situ hybridization probes has seen significant expansion in the past few years. The market is projected to increase from $1.55 billion in 2024 to $1.68 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. The substantial growth experienced in the historical period can be credited to the escalating use of cytogenetic analysis for prenatal tests, an increase in academic research on chromosomal abnormalities, an upswing in the use of FISH for microbial identification, a surge in government-backed genomics research, and a broadening of capabilities within pathology labs._x000D_
_x000D_
The market for fluorescent in-situ hybridization (FISH) probes is projected to witness robust growth in the near future, expanding to a valuation of $2.23 billion by 2029, at a CAGR of 7.4%. Factors driving growth throughout the predicted period include increased use in research and diagnostics, surging demand for multiplexed probe solutions for diagnosing rare diseases, enhanced emphasis on automation within cytogenetic testing processes, growing application of FISH in liquid biopsies, and wider use in genomics research for plants and animals. Major trends forecasted for the said period comprise progress in probe signal amplification techniques, introduction of nano-enabled FISH platforms, innovative developments in automation-compatible FISH assay kits, advanced machine learning application in probe design, and an expansion in 3D FISH imaging applications._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=27289&type=smp_x000D_
_x000D_
#Which Factors Are Pushing The Fluorescent In Situ Hybridization Probe Market Forward?#_x000D_
The burgeoning popularity of personalized medicine is predicted to stimulate expansion in the fluorescent in situ hybridization probe market. Personalized medicine employs the data pertaining to an individual’s genetic makeup and lifestyle environment to formulate bespoke healthcare and therapeutic strategies. Boosted by favorable public inclination towards health technologies offering in-time monitoring and individualized treatment plans, personalized medicine has seen a steep rise in popularity. Fluorescent in situ hybridization (FISH) probes play a crucial role in personalized medicine by facilitating accurate identification of genetic anomalies at the chromosomal extent, thus prompting therapeutic choices based on a person’s specific genetic composition. For example, in February 2023, the Personalized Medicine Coalition, an American professional membership organization, claimed that the sanctioning of 12 novel personalized medicines in 2022, constituting roughly 34% of all newly approved therapies, showed a significant rise from the preceding years. Consequently, the rising popularity of personalized medicine is propelling the expansion of the fluorescent in situ hybridization probe market._x000D_
_x000D_
#Which Segment Held The Largest Share In The Fluorescent In Situ Hybridization Probe Market In 2025?#_x000D_
The fluorescent in situ hybridization probe market covered in this report is segmented_x000D_
_x000D_
1) By Type: Deoxyribonucleic Acid (DNA) Probes, Ribonucleic Acid (RNA) Probes, Multiplex Probes_x000D_
2) By Target: Genes, Chromosomes, Other Targets_x000D_
3) By Technology: Single-Color Fluorescence In Situ Hybridization (FISH), Multiplex Fluorescence In Situ Hybridization (FISH), Quantitative Fluorescence In Situ Hybridization (FISH), Others Technologies _x000D_
4) By Application: Clinical Diagnostics, Research Applications, Agricultural Biotechnology, Pharmaceutical Research, Genetic Research _x000D_
5) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies_x000D_
_x000D_
Subsegments:_x000D_
1) By Deoxyribonucleic Acid (DNA) Probes: Centromeric Probes, Telomeric Probes, Whole Chromosome Paint Probes, Locus-Specific Identifier (LSI) Probes, Comparative Genomic Hybridization (CGH) Probes, Gene Fusion Probes_x000D_
2) By Ribonucleic Acid (RNA) Probes: mRNA Probes, Long Non-Coding RNA (lncRNA) Probes, MicroRNA (miRNA) Probes, Single-Molecule RNA FISH Probes (smFISH), Circular RNA (circRNA) Probes, Multiplexed Error-Robust FISH (MERFISH) Probes_x000D_
3) By Multiplex Probes: Multicolor DNA FISH Probes, Multigene Expression Analysis Probes, High-Throughput Screening Probes, Multiplex smFISH Probes, Combinatorial Barcoded Probes, Simultaneous DNA/RNA Detection Probes_x000D_
_x000D_
#How Are Key Trends Driving Expansion In The Fluorescent In Situ Hybridization Probe Industry?#_x000D_
Leading firms within the fluorescent in situ hybridization (FISH) probe market are working towards building strategic partnerships that will enable them to venture into new markets and technologies, or expertise that could otherwise be hard or expensive to procure individually. A strategic collaboration implicates a structured alliance between two or more organizations who join forces and pool resources to accomplish mutually beneficial, long-term objectives. To illustrate, in April 2025, Empire Genomics, an American molecular diagnostics firm, teamed up with BioDot, a US-based dispenser of precision automation, to introduce the BDot Probe Line. This product provides an exclusive solution by offering FISH probes pre-optimized for automated systems, thereby answering a significant problem in molecular pathology and clinical cytogenetics labs. These probes are constructed for immediate use without requiring manual alterations, guaranteeing seamless operation with the Biodot CellWriter S system. This technological advancement minimizes the need for staff intervention, improves efficiency, and decreases the time to produce results. The initial group of BDot Probe Panels are capable of supporting FISH analysis for an array of blood-related malignancies, which include MM, MDS, CML, AML, ALL, and other prevalent hematologic ailments._x000D_
_x000D_
#Which Organizations Are Driving Progress In The Fluorescent In Situ Hybridization Probe Industry?#_x000D_
Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., and Cytocell Technologies Limited. _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
_x000D_
#Which Region Is Expected To Experience The Highest Growth In The Fluorescent In Situ Hybridization Probe Industry?#_x000D_
North America was the largest region in the fluorescent in situ hybridization probe market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=27289&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model